Drug profile · INN
carbinoxamine maleate
CARBINOXAMINE MALEATE
carbinoxamine maleate (CARBINOXAMINE MALEATE) is a histamine h1 receptor antagonist. Associated with AYTU BIOPHARMA, INC. Route of administration: oral. Current US regulatory status: approved.
Drug details — carbinoxamine maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 5
- Programs
- 3
- Data quality
- 0.89
Quick answer
carbinoxamine maleate (CARBINOXAMINE MALEATE) is a histamine h1 receptor antagonist. Associated with AYTU BIOPHARMA, INC. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is carbinoxamine maleate?
carbinoxamine maleate (CARBINOXAMINE MALEATE) is a histamine h1 receptor antagonist. Associated with AYTU BIOPHARMA, INC. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for carbinoxamine maleate?
CARBINOXAMINE MALEATE is a marketed brand name for carbinoxamine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carbinoxamine maleate?
carbinoxamine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.